SE522410C2 - Beta 1-3-glukanderivat med immunomodulerande verkan - Google Patents

Beta 1-3-glukanderivat med immunomodulerande verkan

Info

Publication number
SE522410C2
SE522410C2 SE9702173A SE9702173A SE522410C2 SE 522410 C2 SE522410 C2 SE 522410C2 SE 9702173 A SE9702173 A SE 9702173A SE 9702173 A SE9702173 A SE 9702173A SE 522410 C2 SE522410 C2 SE 522410C2
Authority
SE
Sweden
Prior art keywords
approx
carbohydrate
carbohydrate derivatives
derivatives according
hydrocarbon chain
Prior art date
Application number
SE9702173A
Other languages
English (en)
Swedish (sv)
Other versions
SE9702173D0 (sv
SE9702173L (sv
Inventor
Rolf Seljelid
Original Assignee
Biotec Pharmacon Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotec Pharmacon Asa filed Critical Biotec Pharmacon Asa
Priority to SE9702173A priority Critical patent/SE522410C2/sv
Publication of SE9702173D0 publication Critical patent/SE9702173D0/xx
Priority to ES98924684T priority patent/ES2236906T3/es
Priority to DE69828503T priority patent/DE69828503T2/de
Priority to PCT/NO1998/000170 priority patent/WO1998055513A1/en
Priority to ZA984896A priority patent/ZA984896B/xx
Priority to AT98924684T priority patent/ATE286512T1/de
Priority to AU76788/98A priority patent/AU7678898A/en
Priority to ARP980102692A priority patent/AR015862A1/es
Priority to EP98924684A priority patent/EP0986579B1/de
Priority to SA98190119A priority patent/SA98190119A/ar
Publication of SE9702173L publication Critical patent/SE9702173L/
Priority to NO19995985A priority patent/NO325950B1/no
Priority to US09/455,464 priority patent/US6423832B1/en
Publication of SE522410C2 publication Critical patent/SE522410C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
SE9702173A 1997-06-06 1997-06-06 Beta 1-3-glukanderivat med immunomodulerande verkan SE522410C2 (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SE9702173A SE522410C2 (sv) 1997-06-06 1997-06-06 Beta 1-3-glukanderivat med immunomodulerande verkan
EP98924684A EP0986579B1 (de) 1997-06-06 1998-06-05 Neue kohlenhydrate und ihre verwendung
AU76788/98A AU7678898A (en) 1997-06-06 1998-06-05 New carbohydrates and use thereof
DE69828503T DE69828503T2 (de) 1997-06-06 1998-06-05 Neue kohlenhydrate und ihre verwendung
PCT/NO1998/000170 WO1998055513A1 (en) 1997-06-06 1998-06-05 New carbohydrates and use thereof
ZA984896A ZA984896B (en) 1997-06-06 1998-06-05 Carbohydrates and use thereof
AT98924684T ATE286512T1 (de) 1997-06-06 1998-06-05 Neue kohlenhydrate und ihre verwendung
ES98924684T ES2236906T3 (es) 1997-06-06 1998-06-05 Nuevos hidratos de carbono y su uso.
ARP980102692A AR015862A1 (es) 1997-06-06 1998-06-05 Nuevos hidratos de carbono, uso de los mismos y metodo para su preparacion
SA98190119A SA98190119A (ar) 1997-06-06 1998-06-06 مركبات كربوهيدراتية جديدة واستخدامها
NO19995985A NO325950B1 (no) 1997-06-06 1999-12-06 Nye karbohydrater og anvendelse derav
US09/455,464 US6423832B1 (en) 1997-06-06 1999-12-06 Carbohydrates and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702173A SE522410C2 (sv) 1997-06-06 1997-06-06 Beta 1-3-glukanderivat med immunomodulerande verkan

Publications (3)

Publication Number Publication Date
SE9702173D0 SE9702173D0 (sv) 1997-06-06
SE9702173L SE9702173L (sv) 1998-12-07
SE522410C2 true SE522410C2 (sv) 2004-02-10

Family

ID=20407285

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9702173A SE522410C2 (sv) 1997-06-06 1997-06-06 Beta 1-3-glukanderivat med immunomodulerande verkan

Country Status (11)

Country Link
US (1) US6423832B1 (de)
EP (1) EP0986579B1 (de)
AR (1) AR015862A1 (de)
AT (1) ATE286512T1 (de)
AU (1) AU7678898A (de)
DE (1) DE69828503T2 (de)
ES (1) ES2236906T3 (de)
SA (1) SA98190119A (de)
SE (1) SE522410C2 (de)
WO (1) WO1998055513A1 (de)
ZA (1) ZA984896B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7018986B2 (en) * 2002-09-20 2006-03-28 Immudyne Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption
MX2007013725A (es) 2005-05-05 2008-04-09 Sensient Flavors Inc Produccion de beta-glucanos y mananos.
IL181431A0 (en) * 2007-02-19 2007-07-04 Micha Shemer Fruit juice and puree with a lowered amount of available sugars
US20100267661A1 (en) * 2009-03-17 2010-10-21 Immudyne, Inc. Beta glucans and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE456911B (sv) * 1983-12-19 1988-11-14 Olle Larm Vattenloeslig, aminerad beta-1,3-bunden d-glukan och makrofagstimulerande komposition innehaallande densamma
SE466289B (sv) * 1984-09-19 1992-01-27 James Hoffman Makrofagstimulerande komposition jaemte foerfarande foer dess framstaellning
JPH04214701A (ja) 1990-12-11 1992-08-05 Shin Etsu Chem Co Ltd β−１，３−グルカン誘導体およびその製造方法

Also Published As

Publication number Publication date
WO1998055513A8 (en) 1999-07-15
ZA984896B (en) 1999-01-07
US6423832B1 (en) 2002-07-23
ATE286512T1 (de) 2005-01-15
SE9702173D0 (sv) 1997-06-06
WO1998055513A1 (en) 1998-12-10
EP0986579B1 (de) 2005-01-05
AU7678898A (en) 1998-12-21
AR015862A1 (es) 2001-05-30
SA98190119A (ar) 2005-12-03
SE9702173L (sv) 1998-12-07
DE69828503T2 (de) 2005-06-23
ES2236906T3 (es) 2005-07-16
EP0986579A1 (de) 2000-03-22
DE69828503D1 (de) 2005-02-10

Similar Documents

Publication Publication Date Title
CN110643032B (zh) 一种八臂聚乙二醇、制备方法、官能化衍生物及修饰的生物相关物质
Zhang et al. A review on biomass-derived levulinic acid for application in drug synthesis
EP0281809A2 (de) Zusammensetzungen mit verzögerter Wirkstoffabgabe für eine parenterale Verabreichung und ihre Verwendung
Qiu et al. Aminated β-Glucan with immunostimulating activities and collagen composite sponge for wound repair
JP2006083186A (ja) 駆虫活性化合物を含む薬剤組成物
SE522410C2 (sv) Beta 1-3-glukanderivat med immunomodulerande verkan
JP5866693B2 (ja) 大腸癌の前癌病変発生抑制剤及び方法
CA2771056A1 (fr) Octasaccharides n-acyles activateurs des recepteurs des fgfs, leur preparation et leur application en therapeutique
US20120129919A1 (en) Polycationic amphiphilic cyclooligosaccharides and the use thereof as molecular transporters
WO2015197652A1 (fr) Mannosylglycerate et ses derives pour utilisation en tant qu'agent immunostimulant
EP2611854A1 (de) Dendrimere mit terminalem saccharid zur entzündungshemmung
JP7576336B2 (ja) １６α－ブロモ－３β－ヒドロキシ－５α－アンドロスタン－１７－ケトンおよびその水和物、誘導体および類似体を含む水性懸濁液組成物、製剤および水分散性乾燥組成物
US9221861B2 (en) Multivalent [beta]-1-2-linked mannose oligosaccharides as immunostimulatory compounds and uses thereof
WO2007009265A1 (en) NOVEL β-CYCLODEXTRIN-BASED MOLECULES AND DRUG DELIVERY COMPOSITIONS
NO325950B1 (no) Nye karbohydrater og anvendelse derav
EP2102222A2 (de) Verwendung von modifizierten oligo-b-(1,3)-glucanen zur behandlung von erkrankungen des immunsystems, oligo-b- (1,3v-glucan-(1,3)- mannose, oligo-b-(1,3)-glucan-(1,3)- mannitol und seine derivate, herstellungsverfahren dafür und wirkstoffe damit
CN103443114A (zh) 激活fgf受体的3-o-烷基寡糖、其制备及其治疗用途
EP2638056B1 (de) Verwendung von 2',5'-oligoadenylatderivatverbindungen
Iurea et al. Modified steroidal glycosides with potential biological activity
HK40060651A (en) Aqueous suspension compositions, formulations, and water dispersible dry compositions comprising 16alpha-bromo-3beta-hydroxy-5alpha-androstan-17-ketone and hydrates, derivatives, and analogs thereof
CN120965905A (zh) 硬尖神香草多糖、其制备方法和应用
FR2664813A1 (fr) Compositions a base de substances hydrophobes, solubilisables dans un solvant aqueux, leur procede d'obtention, et leurs utilisations notamment dans le domaine pharmaceutique.
KR20070067764A (ko) 아졸계 항진균제를 포함하는 조성물 및 그의 제조방법

Legal Events

Date Code Title Description
NUG Patent has lapsed